PAS
NAVB

Partnervest Advisory Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Partnervest Advisory Services’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10
Closed -$1K – 1118
2013
Q3 		$1K Hold
10
– – ﹤0.01% 985
2013
Q2 		$1K Buy
+10
New +$499 ﹤0.01% 929

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Partnervest Advisory Services's NAVB Position: Q4 2013 in Review

Partnervest Advisory Services sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2013, closing a stake of 10 shares — an estimated $1K sold.

Partnervest Advisory Services first reported a position in NAVB in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 87 funds tracked by Wall St. Rank hold NAVB as of Q4 2013.

  • Partnervest Advisory Services reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2013 after selling out during the quarter.
  • Partnervest Advisory Services sold 10 Navidea Biopharmaceuticals Inc. shares in Q4 2013, an estimated $1K.
  • Partnervest Advisory Services first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 2 quarters.
  • Partnervest Advisory Services's Navidea Biopharmaceuticals Inc. position peaked at $1K in Q3 2013.
  • 87 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2013.

Based on Partnervest Advisory Services's 13F filing for Q4 2013, filed 11 Feb 2014.